Status:
COMPLETED
Effect of Selenium Supplementation on Inflammatory,Oxidative and Nutritional Markers in Hemodialysis Patients
Lead Sponsor:
Zahra Sohrabi
Collaborating Sponsors:
Shiraz University of Medical Sciences
Conditions:
Inflammation
Malnutrition
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
The aim of this study is to evaluate the effect of selenium supplementation on oxidative, inflammatory and nutritional markers in hemodialysis patients.
Detailed Description
After screening all of 280 patients under regular HD in Faghihi Hospital Hemodialysis Center, 80 stable patients in the age range of 18-80 years old were found to be eligible for enrollment and gave t...
Eligibility Criteria
Inclusion
- Patients who were dialyzed three times a week at least for 3 months or more
Exclusion
- Patients who took any multivitamins or immunosuppressive drugs within 2 months prior to enrollment in the study
- Patients consuming antioxidant supplements including vitamin E, vitamin C, lipoic acid,omega-3 fatty acids, soy extracts and green-tea preparations within 2 months prior to enrollment in the study
- Patients who were Hospitalized in the previous month
- Patients who had active infections
- Being pregnant
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01147354
Start Date
April 1 2009
End Date
September 1 2009
Last Update
February 2 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shiraz University of Medical Sciences
Shiraz, Fars, Iran